CC250110P17000
- 0.10
- 0.000.00%
The Chemours Newsroom
BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Raises Target Price to $34
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields
Is The Chemours Company (NYSE:CC) Trading At A 50% Discount?
Goldman Sachs Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $21
Chemours Is Maintained at Neutral by Goldman Sachs
Chemours Price Target Cut to $21.00/Share From $24.00 by Goldman Sachs
Express News | Chemours Co - Board Increases Size From Ten to Eleven Members
Express News | Chemours Appoints Google Executive Joseph Kava to Its Board of Directors
Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating, Announces Target Price $21
Mizuho Trims Price Target on Chemours to $21 From $22, Maintains Neutral Rating
Chemours Company (NYSE:CC): A Bullish Investment Perspective
When Should You Buy The Chemours Company (NYSE:CC)?
Here's Buckley Capital's Updates on Chemours (CC)
Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $25
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks Delivering High-Dividend Yields
Price Over Earnings Overview: Chemours
Worst Performing Stocks for Tax Loss Selling – Wolfe
Jefferies Maintains The Chemours(CC.US) With Hold Rating, Raises Target Price to $21
Express News | Chemours : Jefferies Raises Target Price to $21 From $20
Chemours Analyst Ratings